Voyager Therapeutics (United States) belongs to the biomedical and genetics industry.
1 report, 1 independent
Updated Aug 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Voyager Therapeutics (United States) belongs to the biomedical and genetics industry.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Voyager Therapeutics (United States)
company in Cambridge, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksVoyager Therapeutics (VYGR) Reports Q2 Loss, Lags Revenue Estimates Voyager Therapeutics (VYGR) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.4